Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03070236

PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
912 (actual)
Sponsor
Dana-Farber Cancer Institute · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This research study is evaluating how patients feel physically and emotionally after a prior breast biopsy for specific breast conditions (including atypical lesions such as atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS), and/or ductal carcinoma in situ (DCIS))

Detailed description

The goal of this research is to better understand the experience of women who have been diagnosed with certain breast conditions to enable women (and their doctors) to make informed decisions about their care.

Conditions

Interventions

TypeNameDescription
OTHERSurveySelect questions will be ask in the survey

Timeline

Start date
2017-12-01
Primary completion
2019-05-27
Completion
2030-02-25
First posted
2017-03-03
Last updated
2026-02-03
Results posted
2020-03-09

Locations

6 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03070236. Inclusion in this directory is not an endorsement.